nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC52A2—saliva-secreting gland—thyroid cancer	0.0373	0.147	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—trachea—thyroid cancer	0.0288	0.113	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—thyroid gland—thyroid cancer	0.0228	0.0896	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—saliva-secreting gland—thyroid cancer	0.0212	0.0835	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—trachea—thyroid cancer	0.0172	0.0675	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—trachea—thyroid cancer	0.0164	0.0644	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—lymph node—thyroid cancer	0.0141	0.0556	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—thyroid gland—thyroid cancer	0.0136	0.0534	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—thyroid gland—thyroid cancer	0.013	0.051	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—head—thyroid cancer	0.012	0.0474	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—head—thyroid cancer	0.0115	0.0452	CbGeAlD
Gamma Hydroxybutyric Acid—GABRB1—head—thyroid cancer	0.00924	0.0363	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—lymph node—thyroid cancer	0.00843	0.0332	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—thyroid gland—thyroid cancer	0.00825	0.0324	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—lymph node—thyroid cancer	0.00805	0.0317	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—head—thyroid cancer	0.00732	0.0288	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism—RXRA—thyroid cancer	0.00701	0.0851	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—NDUFA13—thyroid cancer	0.006	0.073	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—lymph node—thyroid cancer	0.00512	0.0202	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00461	0.056	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—RXRA—thyroid cancer	0.00424	0.0515	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism—RXRA—thyroid cancer	0.00378	0.046	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00364	0.0443	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—NDUFA13—thyroid cancer	0.00324	0.0394	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—RXRA—thyroid cancer	0.00229	0.0278	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00209	0.0255	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00209	0.0255	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00197	0.0239	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Arthralgia—Sorafenib—thyroid cancer	0.00183	0.00276	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00182	0.00274	CcSEcCtD
Gamma Hydroxybutyric Acid—Hiccups—Epirubicin—thyroid cancer	0.00182	0.00274	CcSEcCtD
Gamma Hydroxybutyric Acid—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.00182	0.00274	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00182	0.00274	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis contact—Epirubicin—thyroid cancer	0.0018	0.00271	CcSEcCtD
Gamma Hydroxybutyric Acid—Abnormal dreams—Epirubicin—thyroid cancer	0.0018	0.00271	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Sorafenib—thyroid cancer	0.00179	0.0027	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Vandetanib—thyroid cancer	0.00178	0.00269	CcSEcCtD
Gamma Hydroxybutyric Acid—Cystitis noninfective—Epirubicin—thyroid cancer	0.00178	0.00268	CcSEcCtD
Gamma Hydroxybutyric Acid—Creatinine increased—Doxorubicin—thyroid cancer	0.00177	0.00267	CcSEcCtD
Gamma Hydroxybutyric Acid—Cystitis—Epirubicin—thyroid cancer	0.00176	0.00265	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Sorafenib—thyroid cancer	0.00175	0.00263	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Sorafenib—thyroid cancer	0.00173	0.00261	CcSEcCtD
Gamma Hydroxybutyric Acid—Fluid retention—Epirubicin—thyroid cancer	0.00173	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Sorafenib—thyroid cancer	0.00172	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Vandetanib—thyroid cancer	0.00172	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00172	0.00259	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Sorafenib—thyroid cancer	0.00171	0.00257	CcSEcCtD
Gamma Hydroxybutyric Acid—Hiccups—Doxorubicin—thyroid cancer	0.00168	0.00254	CcSEcCtD
Gamma Hydroxybutyric Acid—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.00168	0.00254	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Sorafenib—thyroid cancer	0.00168	0.00252	CcSEcCtD
Gamma Hydroxybutyric Acid—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00167	0.00252	CcSEcCtD
Gamma Hydroxybutyric Acid—Abnormal dreams—Doxorubicin—thyroid cancer	0.00166	0.00251	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis contact—Doxorubicin—thyroid cancer	0.00166	0.00251	CcSEcCtD
Gamma Hydroxybutyric Acid—Coma—Epirubicin—thyroid cancer	0.00166	0.00251	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Vandetanib—thyroid cancer	0.00166	0.0025	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00166	0.0201	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00166	0.0201	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mouth ulceration—Epirubicin—thyroid cancer	0.00165	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Ecchymosis—Epirubicin—thyroid cancer	0.00165	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Bladder pain—Epirubicin—thyroid cancer	0.00165	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Cystitis noninfective—Doxorubicin—thyroid cancer	0.00165	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—RXRA—thyroid cancer	0.00164	0.02	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Vandetanib—thyroid cancer	0.00164	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Vandetanib—thyroid cancer	0.00164	0.00247	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Vandetanib—thyroid cancer	0.00163	0.00246	CcSEcCtD
Gamma Hydroxybutyric Acid—Cystitis—Doxorubicin—thyroid cancer	0.00163	0.00245	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0016	0.00241	CcSEcCtD
Gamma Hydroxybutyric Acid—Fluid retention—Doxorubicin—thyroid cancer	0.0016	0.00241	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertonia—Epirubicin—thyroid cancer	0.0016	0.00241	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disability—Epirubicin—thyroid cancer	0.00158	0.00238	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00157	0.0191	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Sorafenib—thyroid cancer	0.00157	0.00236	CcSEcCtD
Gamma Hydroxybutyric Acid—Lymphadenopathy—Epirubicin—thyroid cancer	0.00155	0.00233	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Vandetanib—thyroid cancer	0.00155	0.00233	CcSEcCtD
Gamma Hydroxybutyric Acid—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00155	0.00233	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Sorafenib—thyroid cancer	0.00155	0.00233	CcSEcCtD
Gamma Hydroxybutyric Acid—Coma—Doxorubicin—thyroid cancer	0.00154	0.00232	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Sorafenib—thyroid cancer	0.00153	0.0023	CcSEcCtD
Gamma Hydroxybutyric Acid—Ecchymosis—Doxorubicin—thyroid cancer	0.00152	0.0023	CcSEcCtD
Gamma Hydroxybutyric Acid—Bladder pain—Doxorubicin—thyroid cancer	0.00152	0.0023	CcSEcCtD
Gamma Hydroxybutyric Acid—Mouth ulceration—Doxorubicin—thyroid cancer	0.00152	0.0023	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00152	0.00229	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00152	0.00229	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Sorafenib—thyroid cancer	0.00152	0.00228	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Sorafenib—thyroid cancer	0.0015	0.00227	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Sorafenib—thyroid cancer	0.0015	0.00227	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertonia—Doxorubicin—thyroid cancer	0.00148	0.00223	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disability—Doxorubicin—thyroid cancer	0.00146	0.0022	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00144	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00143	0.00216	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00141	0.00212	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Sorafenib—thyroid cancer	0.0014	0.0021	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Sorafenib—thyroid cancer	0.00139	0.00209	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain in extremity—Epirubicin—thyroid cancer	0.00132	0.00199	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Sorafenib—thyroid cancer	0.00129	0.00195	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Sorafenib—thyroid cancer	0.00126	0.0019	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Epirubicin—thyroid cancer	0.00124	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00124	0.0151	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Epirubicin—thyroid cancer	0.00124	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—Dehydration—Epirubicin—thyroid cancer	0.00123	0.00185	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain in extremity—Doxorubicin—thyroid cancer	0.00122	0.00184	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Epirubicin—thyroid cancer	0.00121	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Sorafenib—thyroid cancer	0.0012	0.00181	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00119	0.00179	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Epirubicin—thyroid cancer	0.00118	0.00178	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00117	0.00176	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Epirubicin—thyroid cancer	0.00117	0.00176	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Sorafenib—thyroid cancer	0.00116	0.00175	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal distension—Epirubicin—thyroid cancer	0.00115	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Doxorubicin—thyroid cancer	0.00115	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00115	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Epirubicin—thyroid cancer	0.00114	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—Dehydration—Doxorubicin—thyroid cancer	0.00114	0.00171	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Sorafenib—thyroid cancer	0.00112	0.00168	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00112	0.00168	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Sorafenib—thyroid cancer	0.00111	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Sorafenib—thyroid cancer	0.00111	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.0011	0.00166	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Sorafenib—thyroid cancer	0.0011	0.00166	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00109	0.00165	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Doxorubicin—thyroid cancer	0.00108	0.00163	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00108	0.00163	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MINPP1—thyroid cancer	0.00106	0.0129	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00106	0.0129	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—CP—thyroid cancer	0.00106	0.0129	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal distension—Doxorubicin—thyroid cancer	0.00106	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Doxorubicin—thyroid cancer	0.00106	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—Pollakiuria—Epirubicin—thyroid cancer	0.00106	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00105	0.0127	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Sorafenib—thyroid cancer	0.00104	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Epirubicin—thyroid cancer	0.00104	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Epirubicin—thyroid cancer	0.00103	0.00156	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Epirubicin—thyroid cancer	0.00103	0.00155	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Epirubicin—thyroid cancer	0.00102	0.00153	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Epirubicin—thyroid cancer	0.00102	0.00153	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Orphan transporters—RXRA—thyroid cancer	0.00101	0.0123	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Stomatitis—Epirubicin—thyroid cancer	0.000993	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—Pollakiuria—Doxorubicin—thyroid cancer	0.000976	0.00147	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Epirubicin—thyroid cancer	0.000971	0.00146	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Doxorubicin—thyroid cancer	0.000962	0.00145	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Epirubicin—thyroid cancer	0.00096	0.00145	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PRKAR1A—thyroid cancer	0.000956	0.0116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Weight decreased—Doxorubicin—thyroid cancer	0.000956	0.00144	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Epirubicin—thyroid cancer	0.000955	0.00144	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000953	0.00144	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Doxorubicin—thyroid cancer	0.000942	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Doxorubicin—thyroid cancer	0.000942	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Doxorubicin—thyroid cancer	0.000918	0.00138	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Epirubicin—thyroid cancer	0.000916	0.00138	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Epirubicin—thyroid cancer	0.00091	0.00137	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Epirubicin—thyroid cancer	0.000907	0.00137	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NDUFA13—thyroid cancer	0.000905	0.011	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Epirubicin—thyroid cancer	0.000903	0.00136	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Epirubicin—thyroid cancer	0.000901	0.00136	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Doxorubicin—thyroid cancer	0.000898	0.00135	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Epirubicin—thyroid cancer	0.000898	0.00135	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Epirubicin—thyroid cancer	0.000896	0.00135	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000894	0.0109	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000894	0.0109	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Epistaxis—Doxorubicin—thyroid cancer	0.000889	0.00134	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—RXRA—thyroid cancer	0.000888	0.0108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Sinusitis—Doxorubicin—thyroid cancer	0.000884	0.00133	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—NRAS—thyroid cancer	0.000871	0.0106	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Eye disorder—Epirubicin—thyroid cancer	0.000854	0.00129	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Epirubicin—thyroid cancer	0.000852	0.00128	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CHST14—thyroid cancer	0.000851	0.0103	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Cardiac disorder—Epirubicin—thyroid cancer	0.000848	0.00128	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Doxorubicin—thyroid cancer	0.000848	0.00128	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000842	0.00127	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000842	0.0102	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000842	0.0102	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Pharyngitis—Doxorubicin—thyroid cancer	0.000839	0.00127	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000835	0.00126	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Doxorubicin—thyroid cancer	0.000833	0.00126	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000831	0.00125	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Epirubicin—thyroid cancer	0.000829	0.00125	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Doxorubicin—thyroid cancer	0.000829	0.00125	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000828	0.0101	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Immune system disorder—Epirubicin—thyroid cancer	0.000826	0.00124	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Epirubicin—thyroid cancer	0.000824	0.00124	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Epirubicin—thyroid cancer	0.00082	0.00124	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Epirubicin—thyroid cancer	0.000808	0.00122	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Epirubicin—thyroid cancer	0.000801	0.00121	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000797	0.00968	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Malnutrition—Epirubicin—thyroid cancer	0.000796	0.0012	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Doxorubicin—thyroid cancer	0.00079	0.00119	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Doxorubicin—thyroid cancer	0.000789	0.00119	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Doxorubicin—thyroid cancer	0.000785	0.00118	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Epirubicin—thyroid cancer	0.000781	0.00118	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Epirubicin—thyroid cancer	0.000779	0.00117	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Epirubicin—thyroid cancer	0.000773	0.00116	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Epirubicin—thyroid cancer	0.00077	0.00116	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Doxorubicin—thyroid cancer	0.000767	0.00116	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Epirubicin—thyroid cancer	0.000765	0.00115	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Doxorubicin—thyroid cancer	0.000764	0.00115	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000762	0.00115	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Doxorubicin—thyroid cancer	0.000759	0.00114	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	0.00075	0.00912	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vision blurred—Epirubicin—thyroid cancer	0.00075	0.00113	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Doxorubicin—thyroid cancer	0.000747	0.00113	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Doxorubicin—thyroid cancer	0.000741	0.00112	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Doxorubicin—thyroid cancer	0.000736	0.00111	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Epirubicin—thyroid cancer	0.000736	0.00111	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Epirubicin—thyroid cancer	0.000731	0.0011	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Doxorubicin—thyroid cancer	0.000723	0.00109	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Doxorubicin—thyroid cancer	0.000721	0.00109	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Doxorubicin—thyroid cancer	0.000715	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Epirubicin—thyroid cancer	0.000715	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Epirubicin—thyroid cancer	0.000714	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Doxorubicin—thyroid cancer	0.000712	0.00107	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Doxorubicin—thyroid cancer	0.000708	0.00107	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Epirubicin—thyroid cancer	0.000703	0.00106	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Epirubicin—thyroid cancer	0.000699	0.00105	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Doxorubicin—thyroid cancer	0.000694	0.00105	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Epirubicin—thyroid cancer	0.000689	0.00104	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Epirubicin—thyroid cancer	0.000687	0.00104	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HPGD—thyroid cancer	0.000686	0.00834	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anaemia—Doxorubicin—thyroid cancer	0.000681	0.00103	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Epirubicin—thyroid cancer	0.000677	0.00102	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Epirubicin—thyroid cancer	0.000677	0.00102	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Epirubicin—thyroid cancer	0.000677	0.00102	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Doxorubicin—thyroid cancer	0.000677	0.00102	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Epirubicin—thyroid cancer	0.000675	0.00102	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000673	0.00101	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00067	0.00814	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000669	0.00814	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dry mouth—Epirubicin—thyroid cancer	0.000663	0.000999	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Doxorubicin—thyroid cancer	0.000662	0.000997	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Doxorubicin—thyroid cancer	0.00066	0.000995	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Epirubicin—thyroid cancer	0.000655	0.000987	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Doxorubicin—thyroid cancer	0.000651	0.000981	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Epirubicin—thyroid cancer	0.000649	0.000979	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Doxorubicin—thyroid cancer	0.000647	0.000975	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Epirubicin—thyroid cancer	0.000645	0.000972	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Epirubicin—thyroid cancer	0.000639	0.000963	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Doxorubicin—thyroid cancer	0.000638	0.000962	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	0.000638	0.00775	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervous system disorder—Epirubicin—thyroid cancer	0.000637	0.00096	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Doxorubicin—thyroid cancer	0.000636	0.000958	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IFNA2—thyroid cancer	0.000634	0.0077	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Skin disorder—Epirubicin—thyroid cancer	0.000631	0.000951	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00063	0.00766	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Epirubicin—thyroid cancer	0.000628	0.000946	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Doxorubicin—thyroid cancer	0.000627	0.000945	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Doxorubicin—thyroid cancer	0.000627	0.000945	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Doxorubicin—thyroid cancer	0.000627	0.000945	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Doxorubicin—thyroid cancer	0.000625	0.000942	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000623	0.000938	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Epirubicin—thyroid cancer	0.000619	0.000933	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Doxorubicin—thyroid cancer	0.000613	0.000924	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Doxorubicin—thyroid cancer	0.000606	0.000913	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Doxorubicin—thyroid cancer	0.000601	0.000906	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Doxorubicin—thyroid cancer	0.000597	0.0009	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000592	0.000892	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Doxorubicin—thyroid cancer	0.000591	0.000891	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Doxorubicin—thyroid cancer	0.000589	0.000888	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Epirubicin—thyroid cancer	0.000587	0.000885	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Doxorubicin—thyroid cancer	0.000584	0.00088	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Epirubicin—thyroid cancer	0.000583	0.000879	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000581	0.000876	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Epirubicin—thyroid cancer	0.000579	0.000873	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Epirubicin—thyroid cancer	0.000577	0.00087	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MINPP1—thyroid cancer	0.000575	0.00699	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anorexia—Doxorubicin—thyroid cancer	0.000573	0.000863	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Epirubicin—thyroid cancer	0.000572	0.000862	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Epirubicin—thyroid cancer	0.000565	0.000851	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000561	0.000845	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Epirubicin—thyroid cancer	0.00056	0.000844	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Epirubicin—thyroid cancer	0.000555	0.000837	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Epirubicin—thyroid cancer	0.000555	0.000837	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000547	0.000825	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Doxorubicin—thyroid cancer	0.000544	0.000819	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Doxorubicin—thyroid cancer	0.00054	0.000813	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Doxorubicin—thyroid cancer	0.000536	0.000808	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Epirubicin—thyroid cancer	0.000535	0.000807	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Doxorubicin—thyroid cancer	0.000534	0.000805	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000531	0.0008	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000529	0.00643	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspepsia—Doxorubicin—thyroid cancer	0.000529	0.000797	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Doxorubicin—thyroid cancer	0.000522	0.000787	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000519	0.000782	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Doxorubicin—thyroid cancer	0.000518	0.000781	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PRKAR1A—thyroid cancer	0.000516	0.00628	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urticaria—Epirubicin—thyroid cancer	0.000516	0.000778	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Doxorubicin—thyroid cancer	0.000514	0.000775	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Doxorubicin—thyroid cancer	0.000514	0.000775	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Epirubicin—thyroid cancer	0.000513	0.000774	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Doxorubicin—thyroid cancer	0.000495	0.000746	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000491	0.000741	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.00049	0.00595	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NDUFA13—thyroid cancer	0.000489	0.00594	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Epirubicin—thyroid cancer	0.000478	0.000721	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Doxorubicin—thyroid cancer	0.000477	0.00072	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Doxorubicin—thyroid cancer	0.000475	0.000716	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—NRAS—thyroid cancer	0.000471	0.00572	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Epirubicin—thyroid cancer	0.000466	0.000702	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CHST14—thyroid cancer	0.00046	0.00559	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000454	0.00552	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000454	0.00552	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000447	0.00543	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Epirubicin—thyroid cancer	0.000444	0.00067	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Doxorubicin—thyroid cancer	0.000443	0.000667	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Doxorubicin—thyroid cancer	0.000431	0.00065	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Epirubicin—thyroid cancer	0.000429	0.000647	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Epirubicin—thyroid cancer	0.000413	0.000622	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Doxorubicin—thyroid cancer	0.000411	0.00062	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Epirubicin—thyroid cancer	0.000409	0.000617	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Epirubicin—thyroid cancer	0.000409	0.000617	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Epirubicin—thyroid cancer	0.000407	0.000613	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	0.000405	0.00492	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Doxorubicin—thyroid cancer	0.000397	0.000599	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TPR—thyroid cancer	0.000394	0.00479	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000392	0.00476	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000392	0.00476	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PRKAR1A—thyroid cancer	0.000388	0.00471	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Epirubicin—thyroid cancer	0.000386	0.000581	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000386	0.00469	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Doxorubicin—thyroid cancer	0.000382	0.000576	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Doxorubicin—thyroid cancer	0.000379	0.000571	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Doxorubicin—thyroid cancer	0.000379	0.000571	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Doxorubicin—thyroid cancer	0.000376	0.000567	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HPGD—thyroid cancer	0.000371	0.0045	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000368	0.00447	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Doxorubicin—thyroid cancer	0.000357	0.000538	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	0.000344	0.00418	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNA2—thyroid cancer	0.000342	0.00416	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00034	0.00413	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC5A5—thyroid cancer	0.000295	0.00359	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000293	0.00357	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000286	0.00347	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—BRAF—thyroid cancer	0.000282	0.00343	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—RXRA—thyroid cancer	0.000248	0.00301	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000247	0.003	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—NRAS—thyroid cancer	0.000236	0.00287	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000225	0.00274	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TPR—thyroid cancer	0.000213	0.00259	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PRKAR1A—thyroid cancer	0.000209	0.00254	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—KRAS—thyroid cancer	0.000203	0.00247	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TP53—thyroid cancer	0.000181	0.0022	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HRAS—thyroid cancer	0.000173	0.0021	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000169	0.00206	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC5A5—thyroid cancer	0.000159	0.00194	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PPARG—thyroid cancer	0.000157	0.0019	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—AKT1—thyroid cancer	0.000153	0.00185	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—RXRA—thyroid cancer	0.000134	0.00163	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—HRAS—thyroid cancer	0.00013	0.00158	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—NRAS—thyroid cancer	0.000128	0.00155	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTGS2—thyroid cancer	0.000123	0.0015	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—KRAS—thyroid cancer	0.00011	0.00133	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTEN—thyroid cancer	0.000107	0.0013	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TP53—thyroid cancer	9.76e-05	0.00119	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HRAS—thyroid cancer	9.33e-05	0.00113	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PPARG—thyroid cancer	8.45e-05	0.00103	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—AKT1—thyroid cancer	8.24e-05	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTGS2—thyroid cancer	6.65e-05	0.000808	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—AKT1—thyroid cancer	6.19e-05	0.000752	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTEN—thyroid cancer	5.8e-05	0.000705	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AKT1—thyroid cancer	3.34e-05	0.000406	CbGpPWpGaD
